Loading...
XNAS
IRMD
Market cap1.20bUSD
Dec 05, Last price  
94.57USD
1D
0.69%
1Q
31.37%
Jan 2017
751.98%
IPO
950.78%
Name

IRadimed Corp

Chart & Performance

D1W1MN
XNAS:IRMD chart
P/E
62.55
P/S
16.43
EPS
1.51
Div Yield, %
0.32%
Shrs. gr., 5y
0.81%
Rev. gr., 5y
13.72%
Revenues
73m
+11.71%
7,685,06111,340,09715,653,05731,593,72032,496,54823,081,59230,438,98338,517,14131,717,37241,814,58153,303,14565,562,29673,242,121
Net income
19m
+11.87%
966,0851,936,8902,050,3667,529,9207,214,545499,7646,303,4509,630,9591,369,0019,325,47112,828,48717,192,77619,234,026
CFO
26m
+90.30%
1,509,1561,474,3972,585,7207,649,3309,406,3203,415,9187,376,01510,232,7335,817,49611,258,15610,042,71113,465,01225,624,463
Dividend
Aug 20, 20240.15 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
IPO date
Jul 16, 2014
Employees
123
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT